If you or a loved one have high triglycerides and are at risk for a cardiovascular event, new options may be available.

This trial is testing whether an investigational drug, Epanova (omega-3 fatty acids), can reduce the risk of serious heart problems when taken in combination with a statin. Epanova is already FDA-approved to treat patients with severely high triglycerides.

You or your loved one may be able to take part if you or he/she:
-Are at least 18 years of age;
-Are currently taking a statin;
-Have a low HDL cholesterol level (less than 42 for men, less than 47 for women)
-Have a current triglycerides level of 180-500;
-Are at risk for MACE (major adverse cardiovascular events, such as heart attack or stroke)

Click here to sign up to learn more and to see if you or your loved one may be able to participate.